Comparison of Low Level Light therapy and topical 5% Minoxidil in the management of male patterned baldness

Randomised controlled trial to study the efficacy and safety of low level light therapy and topical 5% minoxidil in the management of androgenetic alopecia in males

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/030007

Enrollment

Registered

2020-12-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Low level light therapy: Three sessions per week - 20 mins each for 6 months Control Intervention1: 5% Minoxidil: 1 ml twice a day for 6 months

Eligibility

Inclusion criteria

Inclusion criteria: Grade 2-5 Norwood - Hamilton classification

Exclusion criteria

Exclusion criteria: 1. use of finasteride or dutasteride within last 6 months 2. Topical hair growth agents within last 3 months 3, History of hair transplantation 4. Systemic disease affecting scalp

Design outcomes

Primary

Measure	Time frame
50% improvement based on likert scaleTimepoint: 6 months	—

Secondary

Measure	Time frame
patient satisfaction score 2 or 3 (moderate satisfaction to satisfaction)Timepoint: 6 months	—

Countries

India

Contacts

Public ContactS Radhakrishnan

Armed Forces Medical College

shekharadvait@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026